Clinical Trials Logo

Migraine Disorders clinical trials

View clinical trials related to Migraine Disorders.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06412965 Completed - Migraine Disorders Clinical Trials

Reliability of Rimegepant for the Acute Treatment of Migraine

Adelphi DSP
Start date: January 2, 2024
Phase:
Study type: Observational

This protocol describes the analysis of the Adelphi Real World (ARW) Migraine Disease Specific Programme(TM) 2022, a cross-sectional study which used both physician and patient surveys to assess the perception of the acute treatment for migraine attacks.

NCT ID: NCT06342232 Completed - Migraine Headaches Clinical Trials

The Efficacy of Neurofeedback Mindfulness in Migraine Management

Start date: September 9, 2021
Phase: N/A
Study type: Interventional

This longitudinal randomized controlled trial explored how long-term practice of neurofeedback mindfulness would be helpful for migraine management when compare dot a similar controlled intervention. All the participants went through assigned 10 minutes practices on a daily basis for 8 weeks. Behavioural reports and migraine characteristics were compared before and after the intervention.

NCT ID: NCT06322550 Completed - Clinical trials for Role-expectancy on Patient Reported Outcomes

Influence of Role-expectancy on Patient Reported Outcomes Among Patients With Migraine: a Randomized Clinical Trial

Start date: October 29, 2019
Phase: N/A
Study type: Interventional

This study was preregistered 2019 under https://osf.io/nczhj. Since JAMA requires a registration with ClinicalTrials.gov, we post-register the study here with the identical informations from OSF (see there) Migraine is frequently associated with motion sickness, vestibular symptoms, and abnormal motion and visual processing. Clinical symptoms and underlying brain mechanisms during self-motion visual stimulation were not yet investigated in this population. Therefore the aim is to investigate the behavioral responses from a visually simulated roller coaster ride of patients with migraine and headache-free controls. In order to verify the effect of response bias, part of the patients with migraine will be informed that the study aims to investigate vestibular disorders instead of headache disorders and that they are invited as healthy controls.

NCT ID: NCT06304675 Completed - Migraine Clinical Trials

Manageable Environmental Factors in Migraine

Start date: September 30, 2023
Phase:
Study type: Observational [Patient Registry]

There is limited and insufficient information on the effects of inappropriate living environments, exposure to allergens, electromagnetic fields and stress factors on the chronicity of migraine. The aim of this study is to investigate the frequency of environmental variables/triggers in episodic and chronic migraine patients and their relationship with clinical variables in the chronic migraine group. The results obtained will be shared not only in the scientific community, but also on workplace health and employer-related platforms, including "Wellbeing" groups.

NCT ID: NCT06245902 Completed - Clinical trials for Migraine With or Without Aura

An Acute Migraine Factorial Study

ANODYNE-1
Start date: February 18, 2017
Phase: Phase 2
Study type: Interventional

The study consists of a screening visit, out-patient treatment of a moderate or severe migraine attack with a single dose of the study medication within 8 weeks, and End-of-Study Visit 2-7 days after dosing.

NCT ID: NCT06243874 Completed - Migraine Clinical Trials

Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Migraine is a chronic disorder that causes disability. Episodic migraine can be managed by prophylactic medical treatment or interventional pain procedures. Interventional methods used in migraine treatment are greater occipital nerve blockade, lesser occipital nerve blockade, supraorbital nerve blockade, infraorbital nerve blockade, sphenopalatine ganglion blockade, botulinum toxin injection and various radiofrequency applications. The effectiveness of greater occipital nerve blockade and transnasal sphenopalatine ganglion blockade in the treatment of migraine has been proven in various studies.We aimed to evaluate the effects of repetitive greater occipital nerve blockade and transnasal sphenopalatine ganglion blockade in patients with episodic migraine.

NCT ID: NCT06231615 Completed - Migraine Clinical Trials

Efficacy of Fascia Exercises in Migraine Patients

Start date: October 10, 2022
Phase: N/A
Study type: Interventional

Migraine, which is characterized by attacks and many accompanying symptoms, negatively affects the quality of life of patients. Although different methods have been tried for migraine, there is no definitive treatment approach yet. The aim of this study is to examine the effect of fascia exercises as a new approach on the symptoms and complaints of migraine patients. The study was completed with 30 volunteer migraine patients. Participants were divided into two groups in a randomized controlled manner. While head-neck and breathing exercises were applied to the control group, fascial pattern exercises were performed in the study group in addition to these exercises. This protocol was applied 2 days a week for 6 weeks. Pain intensity, quality of life and sleep, heart rate changes, depression and anxiety levels and satisfaction levels were evaluated before and after the treatment. Fascial pattern exercises are an effective approach on the symptoms and complaints of migraine patients and can be adopted as a complementary application in migraine treatment. Since this is the first study in this field, it needs to be supported by other studies in order to increase the provability of the effectiveness of the exercises.

NCT ID: NCT06219694 Completed - Chronic Migraine Clinical Trials

Laser Acupuncture for Chronic Migraine

LAFCM
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

A single-blind randomized controlled trial was conducted from January 2022 to September 2023. Chronic migraine patients were randomly assigned in a 1:1 ratio to receive either Laser acupuncture or sham treatment. The co-primary outcomes were changes in monthly migraine days (MMD) and acute headache medications usage days per month from baseline. Evaluations were taken at baseline and each follow-up point.

NCT ID: NCT06197542 Completed - Migraine Disorders Clinical Trials

Effects of Active Release Technique and Instrument Assisted Soft Tissue Mobilization in Patients With Migraine

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

Rationale of this research is to evaluate the outcome of active release technique and Instrument assisted soft tissue mobilization on trigger points in subjects with Migraine. The significance of this study is to identify which technique is superior in alleviating the symptoms of migraine. This study will help gather evidence on the practice of incorporating trigger point therapy in the treatment of Migraine.

NCT ID: NCT06192173 Completed - Migraine Clinical Trials

Patent Foramen Ovale Closure in Migraine

Start date: September 5, 2022
Phase:
Study type: Observational

The goal of this observational study is to retrospectively observe the effect of PFO closure and medication on migraine. The main questions it aims to answer are: - Whether PFO closure is more effective in the treatment of migraine than traditional medical treatment - What factors affect the effectiveness of migraine treatment ? Participants will undergo contrast transthoracic echocardiography to diagnose PFO and evaluate right-to-left shunt. They will be treated with medication and PFO closure respectively according to guidelines. HIT-6 and a questionnaire about migraine were obtained at the baseline and repeated at the 6-month and 12-month follow-up visits. Researchers will compare closure group and drug group to see efficacy of two groups in treating migraine.